3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Leukemia
22
Leukemia, Promyelocytic, Acute
21
Leukemia, Myeloid, Acute
13
Multiple Myeloma
11
Myelodysplastic Syndromes
9
Leukemia, Myelomonocytic, Chronic
8
Neoplasms, Plasma Cell
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Monocytic, Acute
5
Anemia, Refractory, with Excess of Blasts
5
Neoplasms
4
Lymphoma
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Erythroblastic, Acute
4
Central Nervous System Neoplasms
4
Blast Crisis
4
Recurrence
3
Neuroblastoma
3
Neoplasm Metastasis
3
Myeloproliferative Disorders
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Leukemia, Myeloid, Chronic-Phase
3
Interventions
Nivolumab
13
Ipilimumab
10
pembrolizumab
8
cemiplimab
6
Surveys and Questionnaires
6
Biopsy
6
aldesleukin
5
Radiotherapy
5
Interleukin-2
5
Blood Specimen Collection
5
Temozolomide
4
Sirolimus
4
Photochemotherapy
4
Mohs Surgery
4
HhAntag691
4
Fluorouracil
4
Educational Status
4
Cyclophosphamide
4
sonidegib
3
fludarabine phosphate
3
fludarabine
3
avelumab
3
Vemurafenib
3
Surgical Procedures, Operative
3
Radiation
3
Petrolatum
3
Cetuximab
3
Aminolevulinic Acid
3
trametinib
2
dabrafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Skin Neoplasms
×
Arsenic Trioxide
×
Clear all
NCT01791894
2018-06-08
ATO
Stanford University
Phase 1/2
Completed
5 enrolled
9 charts